NEW AGE FOR NUCLEAR MEDICINE
Radioactive drugs are not just diagnosing disease more effectively, they’re now being used for exciting new therapies. They could be revolutionary in fighting cancer in the 21st century, says Sandy McEwan, vice president of radiopharmaceuticals at Ipsen.
Recent News
Volunteers needed for INCA “Patient Insights into Clinical Trials” videos
As many of you know, we are part of INCA (the International Neuroendocrine Cancer Alliance). Our senior patient advocate, Kate Quirk, sits on the INCA Research Committee and one of their current projects is underway to produce a series of "Patient Insights into...
Welcoming Lisa Walker as the New CEO of Neuroendocrine Cancer UK
We’re delighted to announce Lisa Walker as the new CEO of Neuroendocrine Cancer UK. Lisa brings over 20 years of experience in healthcare and charity leadership, including co-founding and leading an organisation supporting people with Crohn’s disease. Having been part...
Taking Control of Cancer Podcast: Episode 31: Uncovering neuroendocrine cancer
Taking Control of Cancer is a podcast series from the North East London Cancer Alliance to help overcome common cancer myths, fears and barriers. The series aims to provide both patients and healthcare professionals with tangible things they can do to help when it...